Mebendazole: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 19: Line 19:
'''  [[Mebendazole description|Description]]'''
'''  [[Mebendazole description|Description]]'''
'''| [[Mebendazole clinical pharmacology|Clinical Pharmacology]]'''
'''| [[Mebendazole clinical pharmacology|Clinical Pharmacology]]'''
'''| [[Mebendazole microbiology|Microbiology]]'''
'''| [[Mebendazole indications and usage|Indications and Usage]]'''
'''| [[Mebendazole indications and usage|Indications and Usage]]'''
'''| [[Mebendazole contraindications|Contraindications]]'''
'''| [[Mebendazole contraindications|Contraindications]]'''

Revision as of 20:50, 6 January 2014

Mebendazole
MEBENDAZOLE® FDA Package Insert
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Mebendazole is a benzimidazole drug that is used to treat infestations by worms including pinworms,roundworms, tapeworms, hookworms, and whipworms. The active ingredient in Pripsen powder is piperazine.

Category

Anthelmintic

US Brand Names

MEBENDAZOLE®

FDA Package Insert

Description | Clinical Pharmacology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages

Mechanism of Action

Mebendazole (C16H13N3O3) causes slow immobilization and death of the worms by selectively and irreversibly blocking uptake of glucose and other nutrients in susceptible adult intestine where helminths dwell. It is a spindle poison that induces chromosome nondisjunction.

References